Pharma Journalist 9038 posts 0 comments

Pfizer and BioNTech SE announced that they have reached an agreement with the European Commission to supply 200 million doses of their investigational BNT162b2 mRNA-based vaccine…
Read More...

Brazil's National Health Surveillance Agency (Anvisa) authorizes resumption of the phase III clinical trial of CoronaVac™, the Inactivated COVID-19 Vaccine, which is sponsored by our…
Read More...

It’s an exciting time for gene therapy! The FDA expects 40-60 gene therapy products to be approved in the US alone before 2030. So, the medical affairs role has never been more vital in…
Read More...

Sagent Pharmaceuticals, a Nichi-Iko Group Company, announced that it has launched its Phase 2 CAMELOT trial to evaluate the safety and efficacy of Camostat Mesilate (Camostat) for the…
Read More...

Medigen Vaccine Biologics Corporation, a biopharmaceutical company focusing on the development and production of vaccines and biologics, and BlueWillow Biologics, Inc., a privately held…
Read More...

Xencor, MorphoSys AG and Incyte (NASDAQ: INCY) today announced a clinical collaboration to investigate the combination of tafasitamab, plamotamab and lenalidomide in patients with…
Read More...

Adagio Therapeutics, Inc., a company developing best-in-class antibodies that broadly neutralize SARS-CoV-2, SARS-CoV-1, and additional potentially emergent coronaviruses, announced the…
Read More...

Forma Therapeutics Holdings, Inc. announced the European Commission granted Orphan Drug designation to Forma’s FT-4202 for the treatment of sickle cell disease (SCD), based on a…
Read More...

ImmunityBio, a privately-held immunotherapy company, and NantKwest, Inc. a clinical-stage, natural killer cell-based therapeutics company, announced they have administered their…
Read More...

Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, announced that it…
Read More...